You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,929,629


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,929,629
Patent landscape, scope, and claims:
Title: Therapeutic compound
Abstract:N,N-Dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate is a non-hygroscopic material which can be used as a pharmaceutical in the treatment of depression.
Inventor(s): Jeffery; James E. (Nottingham, GB2)
Assignee: Boots Company, PLC (Nottingham, GB2)
Application Number:07/342,638
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,929,629

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,929,629

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8531071Dec 17, 1985

International Family Members for US Patent 4,929,629

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0230742 ⤷  Subscribe 2001C/040 Belgium ⤷  Subscribe
Austria 56942 ⤷  Subscribe
Australia 601167 ⤷  Subscribe
Australia 6644286 ⤷  Subscribe
Canada 1266278 ⤷  Subscribe
China 1016245 ⤷  Subscribe
China 86108547 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.